ALHC

Alignment Healthcare, Inc. (ALHC) | Rumor.io

Alignment Healthcare

ALHC

Attention (50-day avg)0%

Attention rank (50-day avg)#1,455

Bullish sentiment (50-day avg)44%

Price to earnings ratio44.1

Market capitalization1.6B

Earnings per share0.18

Dividend yield (TTM)—

Revenue (annual)3.9B

Net income (annual)-978K

Social

What share of all stock conversation is about ALHC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% 0

Sep 18

* The company's revenue has increased by 32% year-over-year, reaching $1.3 billion.
* The adjusted gross profit margin improved by 40 basis points year-over-year, reaching 86.3%.
* The CEO confirmed guidance, and the drop in price is seen as an overreaction to nonsensical news.

Generated by AI

Sentiment

Of the messages about ALHC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	45.45% +22.22	29.78% -57.11	59.2% -38.47
Bearish	—	54.55% -22.22	70.22% +57.11	40.8% +38.47

Bullish· Jun 9

$ALHC stock has seen significant gains, with a 30% surge, due to its technology-driven Medicare Advantage insurance platform focused on personalized care and cost control.
Insider buying of $ALHC stock, including a $197K purchase, is a "we see something you don't" signal, indicating smart money is accumulating the stock despite analyst caution.
$ALHC stock has closed higher 52.3% of the time when showing a bullish MACD signal, indicating a strong technical trend in favor of the stock.

Bearish· Jul 8

The whistleblower lawsuit filed against Alignment Healthcare, Inc. (ALHC) has led to a nearly 17% drop in shares, with allegations of expense misclassification to inflate earnings.
Alignment Healthcare, Inc. (ALHC) executives, including CEO Kao, EVP Konowiecki, President Maroney, and CMO Kim, have sold significant amounts of company stock, with some selling at prices lower than the current market value.
The price action today suggests that Clover (CLOV) is being affected by the whistleblower lawsuit, with some investors speculating that CLOV's stock price is being dragged down by the news.

Generated by AI

Topics

Of the messages about ALHC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	0%	35.14%	32.83%
Announcements	—	0%	56.76%	27.18%
Controversies	—	100%	8.11%	19.45%
Earnings	—	0%	0%	3.16%
Analysts	—	0%	0%	13.57%
Macro	—	0%	0%	3.82%

Apr 7

$ALHC is trading above both 50-day and 200-day moving averages, but RSI at 70.9 signals overbought conditions short-term.
The stock broke above its 50-day MA at $19.49, with volume spiking to 14.9M vs a 10-day average of 2.7M.
$ALHC is consolidating near a key Fibonacci retracement level, with a decisive break above the descending wedge resistance being monitored.

Generated by AI

Community

Of the messages about ALHC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	45.28%	59.12%	51.75%
Newcomers	100%	54.72%	40.88%	48.25%

Regulars· Sep 16

The stock is experiencing heavy trading volumes, with a 19.5% drop in value to $12.88.
A trading strategy involving buying 2 $10 puts and selling 3 $12.5 puts has a potential 88.89% profitability based on 10 trades.
Alignment Healthcare, Inc. has announced a 9M share secondary offering, which has led to a decline of 12.8% in pre-market trading.

Newcomers· Sep 18

Newcomers are drawn to ALHC's low price point, with some even calling for a buy-in at $10.
The company's revenue and adjusted gross profit are highlighted as positives, with revenue up 32% year-over-year and adjusted MBR improving 40 basis points.
A large trade of 4 million shares is seen as a buy signal, with some believing the stock could be a takeover target at this level.

Generated by AI

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

8d agoYahoo! Finance Canada

10 small-cap U.S. healthcare stocks with the weakest momentum grades

11d agoSeeking Alpha

Alignment Healthcare Stock Isn't On Triage, But It's Still Not Worth Buying (NASDAQ:ALHC)

12d agoSeeking Alpha

Is Alignment Healthcare (ALHC) Still About Right After Its 57% Slide?

Alignment Healthcare has seen its share price fall sharply this year, and the swing has pushed investors to focus more squarely on what the current market value implies about its earnings power. With the stock under pressure, the key issue is whether today's valuation still lines up with what the business is actually generating from its Medicare Advantage operations. The share price is down 56.9% year to date, which puts a lot of weight on whether the current market value matches what...

13d agoYahoo Finance Singapore

Alignment healthcare CEO John Kao sells $356,200 in ALHC stock

13d agoInvesting.com

Also Discussed

Investors talking about ALHC also mention

#	Name	Attention
1	OSH - Oak Street Health, Inc.	——
2	WEBs Consumer Staples XLP Defined Volatility ETFDVXP	0%0
3	Enliven Therapeutics, Inc.ELVN	0%0
4	Smith Douglas Homes CorporationSDHC	0%0
5	Freshpet, Inc.FRPT	0%0
6	iShares High Yield Active ETFBRHY	0%0
7	Neumora Therapeutics, Inc. Common StockNMRA	0%0
8	Relay Therapeutics Inc.RLAY	0%new
9	Golden Heaven Group Holdings Ltd.GDHG	0%0
10	State Street My2034 Corporate Bond ETFMYCN	0%0

Alignment Healthcare, Inc.

Healthcare
Healthcare Plans

Alignment Healthcare, Inc. is a managed healthcare company focused on Medicare Advantage plans for seniors in the United States. The company provides a consumer-centric healthcare platform designed to coordinate coverage and care through customized health plan offerings, local provider partnerships, and technology-enabled support. Its services are built to help members navigate benefits, access care, and manage their health through tools such as member portals, mobile apps, concierge-style assistance, and care coordination resources. Alignment Healthcare serves seniors and Medicare beneficiaries in selected U.S. markets, with a business model centered on improving the experience of health plan members while working closely with providers and care teams. Headquartered in Orange, California, Alignment Healthcare plays a specialized role in the managed care sector by combining insurance coverage with clinical and digital support services.

Website

Location

1100 West Town and Country Road

Orange, CA, 92868

United States

Social

What share of all stock conversation is about ALHC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% 0

Sep 18

* The company's revenue has increased by 32% year-over-year, reaching $1.3 billion.
* The adjusted gross profit margin improved by 40 basis points year-over-year, reaching 86.3%.
* The CEO confirmed guidance, and the drop in price is seen as an overreaction to nonsensical news.

Generated by AI

Sentiment

Of the messages about ALHC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	45.45% +22.22	29.78% -57.11	59.2% -38.47
Bearish	—	54.55% -22.22	70.22% +57.11	40.8% +38.47

Bullish· Jun 9

$ALHC stock has seen significant gains, with a 30% surge, due to its technology-driven Medicare Advantage insurance platform focused on personalized care and cost control.
Insider buying of $ALHC stock, including a $197K purchase, is a "we see something you don't" signal, indicating smart money is accumulating the stock despite analyst caution.
$ALHC stock has closed higher 52.3% of the time when showing a bullish MACD signal, indicating a strong technical trend in favor of the stock.

Bearish· Jul 8

The whistleblower lawsuit filed against Alignment Healthcare, Inc. (ALHC) has led to a nearly 17% drop in shares, with allegations of expense misclassification to inflate earnings.
Alignment Healthcare, Inc. (ALHC) executives, including CEO Kao, EVP Konowiecki, President Maroney, and CMO Kim, have sold significant amounts of company stock, with some selling at prices lower than the current market value.
The price action today suggests that Clover (CLOV) is being affected by the whistleblower lawsuit, with some investors speculating that CLOV's stock price is being dragged down by the news.

Generated by AI

Topics

Of the messages about ALHC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	0%	35.14%	32.83%
Announcements	—	0%	56.76%	27.18%
Controversies	—	100%	8.11%	19.45%
Earnings	—	0%	0%	3.16%
Analysts	—	0%	0%	13.57%
Macro	—	0%	0%	3.82%

Apr 7

$ALHC is trading above both 50-day and 200-day moving averages, but RSI at 70.9 signals overbought conditions short-term.
The stock broke above its 50-day MA at $19.49, with volume spiking to 14.9M vs a 10-day average of 2.7M.
$ALHC is consolidating near a key Fibonacci retracement level, with a decisive break above the descending wedge resistance being monitored.

Generated by AI

Community

Of the messages about ALHC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	45.28%	59.12%	51.75%
Newcomers	100%	54.72%	40.88%	48.25%

Regulars· Sep 16

The stock is experiencing heavy trading volumes, with a 19.5% drop in value to $12.88.
A trading strategy involving buying 2 $10 puts and selling 3 $12.5 puts has a potential 88.89% profitability based on 10 trades.
Alignment Healthcare, Inc. has announced a 9M share secondary offering, which has led to a decline of 12.8% in pre-market trading.

Newcomers· Sep 18

Newcomers are drawn to ALHC's low price point, with some even calling for a buy-in at $10.
The company's revenue and adjusted gross profit are highlighted as positives, with revenue up 32% year-over-year and adjusted MBR improving 40 basis points.
A large trade of 4 million shares is seen as a buy signal, with some believing the stock could be a takeover target at this level.

Generated by AI

Alignment Healthcare

Social

Sep 18

Sentiment

Bullish· Jun 9

Bearish· Jul 8

Topics

Apr 7

Community

Regulars· Sep 16

Newcomers· Sep 18

News

Alignment Healthcare stock hits 52-week low at $8.25

2 of Wall Street’s Favorite Stocks Worth Your Attention and 1 We Avoid

10 small-cap U.S. healthcare stocks with the weakest momentum grades

Alignment Healthcare Stock Isn't On Triage, But It's Still Not Worth Buying (NASDAQ:ALHC)

Is Alignment Healthcare (ALHC) Still About Right After Its 57% Slide?

Alignment healthcare CEO John Kao sells $356,200 in ALHC stock

Also Discussed

Alignment Healthcare, Inc.

Company Information

Location

News

Alignment Healthcare stock hits 52-week low at $8.25

2 of Wall Street’s Favorite Stocks Worth Your Attention and 1 We Avoid

10 small-cap U.S. healthcare stocks with the weakest momentum grades

Alignment Healthcare Stock Isn't On Triage, But It's Still Not Worth Buying (NASDAQ:ALHC)

Is Alignment Healthcare (ALHC) Still About Right After Its 57% Slide?

Alignment healthcare CEO John Kao sells $356,200 in ALHC stock

Also Discussed

Social

Sep 18

Sentiment

Bullish· Jun 9

Bearish· Jul 8

Topics

Apr 7

Community

Regulars· Sep 16

Newcomers· Sep 18